Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Explore common zero based budgeting pitfalls and practical remedies to keep your plan on course and your finances steady.
28,655 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A high-net-worth retiree in washington discovers that a single Social Security claiming choice could cut his lifetime...
Visa unveils a new internal platform to extend stablecoin services across its vast payment network, aiming to slash c...
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Anthropic stunned markets with a Series H that values the private AI firm near $1 trillion, signaling a new era for p...
The XRP supply overhang remains a flashpoint as 32.74 billion tokens sit locked in escrow. With a roughly nine-year p...
Bitcoin slides toward $63,000 as a broad market pullback and a record-long negative Coinbase premium weigh on prices....
Snap enters 2026 with a volatile but potentially rewarding path. Analysts weigh user growth, ad monetization, and new...
Analysts outline a path to higher earnings for Southwest in 2026, but fuel costs and customer fees remain key risks. ...
April’s jobs report beat expectations with a surprising payroll gain, yet revisions and sector gaps create a murkier ...